“…Furthermore, the 5-HT and noradrenaline re-uptake inhibitor, duloxetine, has been shown to produce increases in external urethral sphincter EMG activity that were reversed by the nonselective 5-HT receptor antagonist, methiothepin and by the 5-HT2 receptor subtype selective antagonist, 4-isopropyl-7-methyl -9-(2-hydroxy-1-methylpropoxycarbonyl)- 4,6,6A,7,8,9,10, 10A-octahydroindolo-[4,3-fg] quinoline maleate, (LY53857; Thor & Katofiasc, 1995). An involvement of 5-hydroxytryptaminergic systems in regulation of sympathetic neural activity is also well-established (deGroat & Ryall, 1967;McCall, 1984;Lewis & Coote, 1990;Helke et al, 1991), but the specific receptor subtypes mediating various effects are not well-defined.…”